Ohr Pharmaceutical Inc Business Finance Contracts & Agreements
63 Contracts & Agreements
- Assignment Agreements (1 contract)
- Contribution Agreements (1)
- Investment Agreements (1)
- Note Agreements (2)
- Purchase Agreements (9)
- Registration Rights Agreements (3)
- Stock Agreements (11)
- Subscription Agreements (3)
- Trust Agreements (1)
- Underwriting Agreements (3)
- Warrant Agreements (28)
- Form of Subscription and Investment Representation Agreement, dated May 29, 2024 (Filed With SEC on May 31, 2024)
- Redemption and Termination Agreement, dated January 26, 2024, by and between NeuBase Therapeutics, Inc. and the Warrant Holder thereto (Filed With SEC on January 26, 2024)
- Exchange Agreement, dated October 17, 2023, by and between NeuBase Therapeutics, Inc. and the Warrant Holder thereto (Filed With SEC on October 18, 2023)
- Form of Series A-1 Common Stock Purchase Warrant (Filed With SEC on October 18, 2023)
- Registration Rights Agreement, dated June 28, 2023 (Filed With SEC on June 30, 2023)
- Securities Purchase Agreement, dated June 28, 2023 (PIPE Private Placement) (Filed With SEC on June 30, 2023)
- Securities Purchase Agreement, dated June 28, 2023 (Registered Direct Offering) (Filed With SEC on June 30, 2023)
- Form of Placement Agent Common Stock Purchase Warrant (Filed With SEC on June 30, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (PIPE Private Placement) (Filed With SEC on June 30, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Registered Direct Offering) (Filed With SEC on June 30, 2023)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on June 30, 2023)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on June 30, 2023)
- Purchase Agreement, dated December 28, 2022, by and between NeuBase Therapeutics, Inc. and Alumni Capital LP (Filed With SEC on December 29, 2022)
- Underwriting Agreement, dated as of April 22, 2021, by and among NeuBase Therapeutics, Inc. and RBC Capital Markets, LLC, Oppenheimer & Co. Inc. and Chardan Capital Markets LLC,... (Filed With SEC on April 22, 2021)
- Underwriting Agreement, dated as of April 28, 2020, by and between NeuBase Therapeutics, Inc. and Oppenheimer & Co. Inc. and BTIG, LLC, as representatives of the underwriters... (Filed With SEC on April 29, 2020)
- Registration Rights Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signature pages thereto (Filed With SEC on July 12, 2019)
- Common Stock Purchase Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signatures pages thereto (Filed With SEC on July 12, 2019)
- Amendment to Restricted Stock Purchase Agreement, made as of December 26, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on March 8, 2019)
- Restricted Stock Purchase Agreement, made as of September 6, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on March 8, 2019)
- Form of NeuBase Therapeutics, Inc. Convertible Promissory Note (Filed With SEC on March 8, 2019)
- Form of NeuBase Therapeutics, Inc. Note Purchase Agreement (Filed With SEC on March 8, 2019)
- Form of NeuBase Therapeutics, Inc. Warrant Certificate (Filed With SEC on March 8, 2019)
- Form of Restricted Stock Agreement (Filed With SEC on December 15, 2017)
- Form of Stock Option Agreement (Filed With SEC on December 15, 2017)
- Securities Purchase Agreement dated as of April 5, 2017, by and among Ohr Pharmaceutical, Inc. and the purchasers listed therein (Filed With SEC on April 6, 2017)
- Form of Warrant (Filed With SEC on April 6, 2017)
- Form of Securities Purchase Agreement (Filed With SEC on April 4, 2017)
- Form of Warrant (Filed With SEC on April 4, 2017)
- Securities Purchase Agreement, dated December 7, 2016, by and among Ohr Pharmaceutical, Inc. and the purchasers listed therein (Filed With SEC on December 8, 2016)
- Form of Series B Warrant (Filed With SEC on December 8, 2016)
- Form of Series A Warrant (Filed With SEC on December 8, 2016)
- Restricted Stock Agreement, dated December 11, 2015, between Ohr Pharmaceutical, Inc. and Irach B. Taraporewala (Filed With SEC on December 14, 2015)
- Form of Stock Option (Filed With SEC on May 11, 2015)
- Underwriting Agreement, dated February 6, 2015, by and between Ohr Pharmaceutical, Inc. and Cowen and Company, LLC, as representative of the Underwriters named therein (Filed With SEC on February 6, 2015)
- Amendment No. 1 to Warrant Agreement, dated January 15, 2015 (Filed With SEC on January 20, 2015)
- Assignment and Assumption Agreement between Ohr Pharmaceutical, Inc. and Ohr Holdco, Inc., dated May 30, 2014 (Filed With SEC on June 2, 2014)
- Contribution Agreement (Filed With SEC on May 16, 2014)
- Form of Subscription Agreement, dated April 8, 2014, by and among Ohr Pharmaceutical, Inc. and each of the investors (Filed With SEC on April 8, 2014)
- Amendment No. 1 to Warrant Agreement, dated March 11, 2014 (Filed With SEC on March 14, 2014)
- Amendment 3 to Warrant Agreement, Dated April 18, 2013 (Filed With SEC on April 22, 2013)
